A novel combination of existing clinical treatments can instantaneously detect and kill only cancer cells without harming surrounding normal organs, the maiden preclinical study of a new Rice University-developed anti-cancer technology revealed. The research, which is available online this week iNature Medicine/i, reports that Rice's "quadrapeutics" technology was 17 times more efficient than conventional chemoradiation therapy against aggressive, drug-resistant ...
Read More
You have just read an article categorized health
titled 'Quadrapeutics' Shows Promise in Preclinical Study of Hard-to-Treat Tumors.
Written by:
editor -
Monday, June 2, 2014
There are currently no comments for "'Quadrapeutics' Shows Promise in Preclinical Study of Hard-to-Treat Tumors"
Post a Comment